Skip to main content

Testing HER2 in breast cancer: a comparative study on BRISH, FISH, and IHC.

Brügmann A, Lelkaitis G, Nielsen S, Jensen KG, Jensen V

Publication: Appl Immunohistochem Mol Morphol (2011) • Vol 19 • Page 203-11PMID: 21475037View on PubMed

Purpose

The purpose of this paper was to compare two brightfield in-situ hybridization (BRISH) methods, fluorescence in-situ hybridization (FISH), and immunohisotchemical (IHC) staining of tissue microarrays for the determination of human epidermal growth factor receptor 2 (HER2) status in primary breast carcinomas.

Conclusion

Almost perfect agreement between the two IHC methods and FISH was observed (HercepTest 97% and PATHWAY 98%). Agreement between Dual ISH BRISH and FISH was also high (98.5%), while the second BRISH method, DuoCISH showed a slightly lower overall agreement (93%) with FISH results.

Studies (1)

Purpose

The purpose of this study was to compare BRISH, FISH, and IHC analysis of tissue microarrays for the determination of HER2 status in breast carcinoma specimens. Tissue microarrays were prepared from formalin-fixed paraffin-embedded (FFPE) specimens that had been stored between 4 and 22 months. Liver tissue was included in tissue microarrays as a control.

Summary of Findings

HercepTest and PATHWAY showed 97% and 98% agreement with FISH results, respectively, both showed 99.4% specificity, but HercepTest had a lower sensitivity (78.3%) compared to PATHWAY (87%). If FISH results are taken as the reference standard, the same two cases which were misclassified by HercepTest were also misclassified by PATHWAY. In one case, polysomy of both HER2 and CEN17 explained the discrepancy between FISH and the IHC methods, while the other case was equivocal (2.01) by FISH and not amplified by both IHC methods. Almost perfect interobserver agreement was attained for the two BRISH methods. The overall agreement between the Dual ISH BRISH method and FISH was 98.5%, with a sensitivity of 96% and a specificity of 99%. For DuoCISH, the overall agreement with FISH was 93%, specificity was 93% and sensitivity was 96%.

  • Biospecimens

    TissueBreast
    TissueLiver
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    ProteinImmunohistochemistry
    ProteinTissue microarray
    DNAFISH
    DNATissue microarray
    RNAIn situ hybridization
    RNATissue microarray
    MorphologyH-and-E microscopy
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Analyte Extraction and PurificationTemperature of heat-induced retrieval
    95 degrees C (PATHWAY)
    97 degrees C (HercepTest)
    In situ hybridization SpecificTargeted nucleic acid
    CEN17
    HER2
    In situ hybridization SpecificTechnology platform
    Dual ISH (Ventana)
    DuoCISH (Dako)
    Immunohistochemistry SpecificTechnology platform
    HercepTest (Dako)
    PATHWAY (Ventana)
    FISH SpecificTechnology platform
    Immunohistochemistry
    In situ-hybridization